Renato C Monteiro Selected Research

Fc gamma receptor IIA

4/2016	Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis.
11/2005	FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy.
6/2004	Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renato C Monteiro Research Topics

Disease

36	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 10/2002
21	Inflammation (Inflammations) 11/2021 - 03/2002
16	Glomerulonephritis 10/2021 - 02/2003
13	Proteinuria 01/2022 - 02/2003
5	Disease Progression 01/2022 - 04/2007
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 11/2005
5	Neoplasms (Cancer) 04/2021 - 03/2004
5	Infections 01/2021 - 01/2006
5	Sepsis (Septicemia) 01/2019 - 01/2006
5	Nephritis 01/2018 - 02/2003
5	Hematuria 12/2017 - 04/2012
5	Chronic Kidney Failure (Chronic Renal Failure) 12/2015 - 12/2003
4	Rheumatoid Arthritis 01/2019 - 11/2005
4	Purpura 01/2018 - 02/2003
4	Celiac Disease (Celiac Sprue) 09/2012 - 09/2004
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 04/2010
3	Fibrosis (Cirrhosis) 01/2020 - 07/2010
3	Vasculitis (Vasculitides) 01/2018 - 02/2008
2	Chronic Renal Insufficiency 01/2022 - 10/2011
2	Kidney Diseases (Kidney Disease) 01/2022 - 11/2021
2	Necrosis 01/2021 - 03/2011
2	Systemic Vasculitis 01/2018 - 01/2017
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2018 - 10/2007
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 12/2017 - 01/2017
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2017 - 12/2011
2	Hypersensitivity (Allergy) 01/2017 - 03/2004
2	Renal Insufficiency (Renal Failure) 01/2016 - 06/2004
2	Atrophy 08/2015 - 09/2004
2	Segmental glomerulosclerosis 06/2014 - 02/2003
2	Lupus Nephritis 02/2008 - 06/2004
2	Wounds and Injuries (Trauma) 01/2007 - 09/2005
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2005 - 02/2003
1	Dysbiosis 03/2022
1	Polycythemia (Erythrocytosis) 01/2022
1	Hereditary Nephritis (Alport Syndrome) 05/2021
1	Albuminuria 01/2021
1	COVID-19 01/2021
1	Pneumonia (Pneumonitis) 01/2019
1	Common Variable Immunodeficiency 01/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019
1	Immune System Diseases (Immune Disorders) 01/2019
1	Ischemia 12/2017

Drug/Important Bio-Agent (IBA)

39	Immunoglobulin A (IgA)IBA 01/2022 - 03/2002
16	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 12/2003
13	Immunoglobulin G (IgG)IBA 01/2022 - 11/2005
8	AutoantibodiesIBA 01/2022 - 01/2015
8	IgA receptor (protein B)IBA 12/2017 - 10/2002
7	Transferrin Receptors (Transferrin Receptor)IBA 09/2012 - 03/2004
5	Fc(alpha) receptorIBA 01/2022 - 01/2007
5	Immunoglobulins (Immunoglobulin)IBA 08/2021 - 10/2007
5	CytokinesIBA 01/2021 - 03/2004
5	LigandsIBA 01/2021 - 10/2011
4	galactosyl-deficient IgA1IBA 01/2022 - 12/2015
4	Fc Receptors (Fc Receptor)IBA 12/2015 - 11/2007
4	GliadinIBA 08/2015 - 09/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Galactose (Galactopyranose)FDA LinkGeneric 01/2022 - 12/2011
3	AntigensIBA 01/2020 - 03/2004
3	AntibodiesIBA 01/2018 - 08/2015
3	IronIBA 12/2017 - 04/2010
3	Immunoglobulin E (IgE)IBA 01/2017 - 03/2004
3	Fc gamma receptor IIAIBA 04/2016 - 06/2004
3	Glutens (Glutelin)IBA 08/2015 - 01/2008
3	Secretory Immunoglobulin A (SIgA)IBA 09/2013 - 01/2008
2	Complement System Proteins (Complement)IBA 12/2021 - 12/2017
2	B-Cell Activating FactorIBA 04/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 03/2011
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2020 - 08/2015
2	Vitamin D FDA LinkGeneric 01/2020 - 01/2013
2	IgG Receptors (Fc gamma RI)IBA 01/2020 - 01/2006
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 03/2011
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2017 - 03/2004
2	Transferrin (beta 2 Transferrin)IBA 08/2015 - 10/2011
2	Intravenous Immunoglobulins (IVIG)FDA Link 09/2014 - 03/2012
2	Peptides (Polypeptides)IBA 04/2012 - 01/2008
2	Monoclonal AntibodiesIBA 02/2007 - 03/2004
2	micaIBA 09/2004 - 08/2003
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Biological ProductsIBA 05/2021
1	Rifaximin (L 105)FDA Link 04/2021
1	Messenger RNA (mRNA)IBA 04/2021
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 04/2021
1	ChemokinesIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Antimitotic AgentsIBA 01/2020
1	Immunoglobulin Fc FragmentsIBA 01/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018

Therapy/Procedure

3	Therapeutics 01/2019 - 04/2010
3	Kidney Transplantation 12/2015 - 09/2005
2	Fecal Microbiota Transplantation 03/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 04/2010
2	Ligation 01/2019 - 10/2012
2	Punctures 01/2019 - 10/2012
2	Transplantation 04/2018 - 12/2015